Bionano Genomics (BNGO) vs Circle8 Group (CIRC)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Bionano Genomics (BNGO) has outperformed Circle8 Group (CIRC) over the past year, losing 49.2% versus a loss of 94.4%. Over five years, CIRC leads with a -99.9% price change compared with -100.0% for BNGO. Circle8 Group is the larger company by market cap ($16.0 million vs $11.5 million), about 1.4 times the size.
Circle8 Group converts more of its revenue into profit, with a net margin of -13.6% versus -92.6%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BNGO | CIRC |
|---|---|---|
| Share price | $0.8222 | $0.1361 |
| Market cap | $11.50M | $15.99M |
| 1-day change | -7.11% | -12.25% |
| YTD return | -46.26% | -89.77% |
| 1-year return | -49.25% | -94.44% |
| 5-year return | -99.97% | -99.88% |
| EPS (TTM) | $-1.96 | $-2.14 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $28.51M | $435.88M |
| Revenue growth (YoY) | -7.37% | -1.52% |
| Net income (latest FY) | $-26.39M | $-59.43M |
| Gross margin | 46.25% | 10.55% |
| Operating margin | -116.95% | -11.52% |
| Net margin | -92.59% | -13.63% |
| 52-week high | $2.23 | $4.56 |
| 52-week low | $0.81 | $0.136 |
| Distance from 52-week high | -63.13% | -97.02% |
| Analyst consensus | none | — |
| Avg. price target upside | +508.12% | — |
| Average volume | 979.44K | 1.13M |
| Shares outstanding | 13.99M | 117.49M |
| Employees | 95 | 300 |
| Sector | Industrials | Industrials |
| Industry | Biotechnology: Laboratory Analytical Instruments | Biotechnology: Laboratory Analytical Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- BNGO has outperformed CIRC by 45.2 percentage points over the past year.
- Circle8 Group is more profitable, keeping -13.6 cents of every revenue dollar as net income versus -92.6 cents for Bionano Genomics.
- Circle8 Group grew revenue faster in its latest fiscal year (-1.52% vs -7.37%).
About Bionano Genomics
BNGO stock →Bionano Genomics, Inc., together with its subsidiaries, provides genome analysis solutions in the Americas, Europe, the Middle East, Africa, China, Japan, South Korea, Singapore, India, and Australia. The company offers genome analysis software that enables genomics labs to analyze and interpret data across a range of platforms to generate informative data visualizations for streamlined and simple reporting of causal variants.
Industrials · Biotechnology: Laboratory Analytical Instruments · 95 employees
About Circle8 Group
CIRC stock →Circle8 Group, Inc. provides talent management services.
Industrials · Biotechnology: Laboratory Analytical Instruments · 300 employees
BNGO vs CIRC FAQ
Which is bigger, Bionano Genomics or Circle8 Group?
Circle8 Group (CIRC) is larger, with a market capitalization of $15.99M compared with $11.50M for Bionano Genomics (BNGO).
Which stock has performed better over the past year, BNGO or CIRC?
BNGO returned -49.25% over the past 12 months, compared with -94.44% for CIRC (price return, excluding dividends). Past performance does not predict future results.
Are Bionano Genomics and Circle8 Group in the same industry?
Yes. Both are classified in the Biotechnology: Laboratory Analytical Instruments industry within the Industrials sector.